Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, ...

A McGill University study of more than 450,000 patients found that incretin-based Type 2 diabetes drugs, including GLP-1 ...

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...

With regards to his pioglitazone use, he had no history of heart failure, and his ALT level was acceptable at the time of discharge at 25 U/L. Signs and symptoms of heart failure were reviewed with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Most adults with type 2 diabetes receiving an ...

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Data derived from: D ...

Initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2is) was associated with a 34% lower rate of recurrent gout flare compared with initiation of dipeptidyl peptidase 4 inhibitors (DPP-4is).

In a recent large-scale retrospective cohort study published in the journal Primary Care Diabetes, researchers used a comprehensive (n = 10,465) database-derived dataset to evaluate the adherence and ...

In September, Indian drug manufacturer Alembic received a tentative nod from the US Food and Drug Administration (FDA) to manufacture generic alogliptin as well as the alogliptin/metformin fixed-drug ...